Seres Therapeutics (MCRB) Net Equity Issued and Repurchased (2014 - 2026)
Seres Therapeutics' Net Equity Issued and Repurchased was $28,000 in Q1 2026, down 84.8% from $184,000 a year earlier and down 89.7% from the prior quarter.
Powered by 
Analysis
Seres Therapeutics (MCRB) Net Equity Issued and Repurchased (2014 - 2026) Analysis & Trends
For FY2025, Net Equity Issued and Repurchased at Seres Therapeutics came in at $501,000, up 2.9% from FY2024.
- Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -71.0% (FY2020 to FY2025).
- In earlier years, Net Equity Issued and Repurchased was $487,000 in FY2024 (-77.4%), $2.15 million in FY2023 (-97.8%), $96.72 million in FY2022 and $1.3 million in FY2021 (-99.5%).
- The Q1 2026 figure marks the lowest quarterly Net Equity Issued and Repurchased since Q4 2022.
- The best year-over-year quarter for Net Equity Issued and Repurchased over five years was Q1 2022 (growth of 127.6%); the worst was Q3 2023 (a decline of 99.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | -1.60 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | -9.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | -714.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | -1.20 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -346.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | - |
| 10 | Seres Therapeutics | 20.53 Mn | -118.30 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 28,000.00 |
| Dec 31, 2025 | 486,000.00 |
| Sep 30, 2025 | 61,000.00 |
| Mar 31, 2025 | 184,000.00 |
| Sep 30, 2024 | 134,000.00 |
| Mar 31, 2024 | 353,000.00 |
| Sep 30, 2023 | 1.44 Mn |
| Jun 30, 2023 | 168,000.00 |
| Mar 31, 2023 | 1.42 Mn |
| Dec 31, 2022 | -3.13 Mn |
| Sep 30, 2022 | 101.31 Mn |
| Jun 30, 2022 | 130,000.00 |
| Mar 31, 2022 | 1.15 Mn |
| Dec 31, 2021 | 168,000.00 |
| Sep 30, 2021 | 609,000.00 |
| Jun 30, 2021 | 585,000.00 |
| Mar 31, 2021 | 764,000.00 |
| Dec 31, 2020 | 2.08 Mn |
| Sep 30, 2020 | 256.22 Mn |
| Jun 30, 2020 | 15,000.00 |
API Access
Seres Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=MCRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "MCRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=MCRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();